Lee J, Jeon Y, Xin M, Lim J, Lee Y, Kim D
Biochem Biophys Rep. 2022; 30:101253.
PMID: 35378739
PMC: 8976097.
DOI: 10.1016/j.bbrep.2022.101253.
Ribatti D, Annese T, Tamma R
Rom J Morphol Embryol. 2021; 61(4):1051-1056.
PMID: 34171054
PMC: 8343648.
DOI: 10.47162/RJME.61.4.07.
Pereira N, Pinheiro T
Eur J Dent. 2019; 13(1):1-4.
PMID: 31170764
PMC: 6635962.
DOI: 10.1055/s-0039-1688734.
Ribatti D, Tamma R, Vacca A
Int J Mol Sci. 2019; 20(3).
PMID: 30678047
PMC: 6386864.
DOI: 10.3390/ijms20030481.
Guidolin D, Ruggieri S, Annese T, Tortorella C, Marzullo A, Ribatti D
Clin Exp Med. 2017; 17(4):531-539.
PMID: 28105541
DOI: 10.1007/s10238-017-0452-7.
Non-random spatial relationships between mast cells and microvessels in human endometrial carcinoma.
Guidolin D, Marinaccio C, Tortorella C, Annese T, Ruggieri S, Finato N
Clin Exp Med. 2016; 17(1):71-77.
PMID: 26886279
DOI: 10.1007/s10238-016-0407-4.
The Role of Mast Cells in Molding the Tumor Microenvironment.
Rigoni A, Colombo M, Pucillo C
Cancer Microenviron. 2014; 8(3):167-76.
PMID: 25194694
PMC: 4715001.
DOI: 10.1007/s12307-014-0152-8.
Possible biological and translational significance of mast cells density in colorectal cancer.
Marech I, Ammendola M, Gadaleta C, Zizzo N, Oakley C, Gadaleta C
World J Gastroenterol. 2014; 20(27):8910-20.
PMID: 25083063
PMC: 4112891.
DOI: 10.3748/wjg.v20.i27.8910.
Antiproliferative and apoptotic-inducing potential of ellagic acid against 1,2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats.
Umesalma S, Nagendraprabhu P, Sudhandiran G
Mol Cell Biochem. 2013; 388(1-2):157-72.
PMID: 24281858
DOI: 10.1007/s11010-013-1907-0.
Mast Cells in Adjacent Normal Colon Mucosa rather than Those in Invasive Margin are Related to Progression of Colon Cancer.
Xia Q, Ding Y, Wu X, Peng R, Zhou Q, Zeng J
Chin J Cancer Res. 2013; 23(4):276-82.
PMID: 23358806
PMC: 3551301.
DOI: 10.1007/s11670-011-0276-z.
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.
Zaiss D, van Loosdregt J, Gorlani A, Bekker C, Grone A, Sibilia M
Immunity. 2013; 38(2):275-84.
PMID: 23333074
PMC: 3582723.
DOI: 10.1016/j.immuni.2012.09.023.
Mast cells and inflammation-associated colorectal carcinogenesis.
Tanaka T, Ishikawa H
Semin Immunopathol. 2012; 35(2):245-54.
PMID: 22993030
DOI: 10.1007/s00281-012-0343-7.
Mast cells and angiogenesis in gastric carcinoma.
Ribatti D, Guidolin D, Marzullo A, Nico B, Annese T, Benagiano V
Int J Exp Pathol. 2010; 91(4):350-6.
PMID: 20412338
PMC: 2962893.
DOI: 10.1111/j.1365-2613.2010.00714.x.
A comparative study of the spatial distribution of mast cells and microvessels in the foetal, adult human thymus and thymoma.
Raica M, Cimpean A, Nico B, Guidolin D, Ribatti D
Int J Exp Pathol. 2009; 91(1):17-23.
PMID: 20002837
PMC: 2812724.
DOI: 10.1111/j.1365-2613.2009.00689.x.
T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis.
Gounaris E, Blatner N, Dennis K, Magnusson F, Gurish M, Strom T
Cancer Res. 2009; 69(13):5490-7.
PMID: 19570783
PMC: 2881579.
DOI: 10.1158/0008-5472.CAN-09-0304.
Immune cells and angiogenesis.
Ribatti D, Crivellato E
J Cell Mol Med. 2009; 13(9A):2822-33.
PMID: 19538473
PMC: 4498938.
DOI: 10.1111/j.1582-4934.2009.00810.x.
Mast cells as regulators of adaptive immunity to tumours.
Wasiuk A, de Vries V, Hartmann K, Roers A, Noelle R
Clin Exp Immunol. 2008; 155(2):140-6.
PMID: 19077084
PMC: 2675243.
DOI: 10.1111/j.1365-2249.2008.03840.x.
Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer.
Nonomura N, Takayama H, Nishimura K, Oka D, Nakai Y, Shiba M
Br J Cancer. 2007; 97(7):952-6.
PMID: 17848955
PMC: 2360404.
DOI: 10.1038/sj.bjc.6603962.
Peritumoral inflammatory infiltrate is not a prognostic factor in distal rectal cancer following neoadjuvant chemoradiation therapy.
Perez R, Habr-Gama A, Nunes Dos Santos R, Proscurshim I, Campos F, Rawet V
J Gastrointest Surg. 2007; 11(11):1534-40.
PMID: 17786526
DOI: 10.1007/s11605-007-0287-8.
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Rajput A, Turbin D, Cheang M, Voduc D, Leung S, Gelmon K
Breast Cancer Res Treat. 2007; 107(2):249-57.
PMID: 17431762
PMC: 2137942.
DOI: 10.1007/s10549-007-9546-3.